EE522 Cost-Effectiveness of Direct Oral Anticoagulants (DOACS) Versus Low-Molecular-Weight Heparins (LMWH) in Patients with Cancer-Associated Venous Thromboembolism (CAT) in Hong Kong
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.787
https://www.valueinhealthjournal.com/article/S1098-3015(23)03917-7/fulltext
Title :
EE522 Cost-Effectiveness of Direct Oral Anticoagulants (DOACS) Versus Low-Molecular-Weight Heparins (LMWH) in Patients with Cancer-Associated Venous Thromboembolism (CAT) in Hong Kong
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03917-7&doi=10.1016/j.jval.2023.09.787
First page :
Section Title :
Open access? :
No
Section Order :
10274